Positive no-touch surfaces and undetectable SARS-CoV-2 aerosols in long-term care facilities: An attempt to understand the contributing factors and the importance of timing in air sampling campaigns.


Journal

American journal of infection control
ISSN: 1527-3296
Titre abrégé: Am J Infect Control
Pays: United States
ID NLM: 8004854

Informations de publication

Date de publication:
06 2021
Historique:
received: 28 12 2020
revised: 03 02 2021
accepted: 09 02 2021
pubmed: 16 2 2021
medline: 25 6 2021
entrez: 15 2 2021
Statut: ppublish

Résumé

Long-term care facilities (LTCF) are environments particularly favorable to coronavirus disease (SARS-CoV-2) pandemic outbreaks, due to the at-risk population they welcome and the close proximity of residents. Yet, the transmission dynamics of the disease in these establishments remain unclear. Air and no-touch surfaces of 31 rooms from 7 LTCFs were sampled and SARS-CoV-2 was quantified by real-time reverse transcription polymerase chain reaction (RT-qPCR). Air samples were negative but viral genomes were recovered from 20 of 62 surface samples at concentrations ranging from 13 to 36,612 genomes/surface. Virus isolation (culture) from surface samples (n = 7) was negative. The presence of viral RNA on no-touch surfaces is evidence of viral dissemination through air, but the lack of airborne viral particles in air samples suggests that they were not aerosolized in a significant manner during air sampling sessions. The air samples were collected 8 to 30 days after the residents' symptom onset, which could indicate that viruses are aerosolized early in the infection process. Additional research is needed to evaluate viral viability conservation and the potential role of direct contact and aerosols in SARS-CoV-2 transmission in these institutions.

Sections du résumé

BACKGROUND
Long-term care facilities (LTCF) are environments particularly favorable to coronavirus disease (SARS-CoV-2) pandemic outbreaks, due to the at-risk population they welcome and the close proximity of residents. Yet, the transmission dynamics of the disease in these establishments remain unclear.
METHODS
Air and no-touch surfaces of 31 rooms from 7 LTCFs were sampled and SARS-CoV-2 was quantified by real-time reverse transcription polymerase chain reaction (RT-qPCR).
RESULTS
Air samples were negative but viral genomes were recovered from 20 of 62 surface samples at concentrations ranging from 13 to 36,612 genomes/surface. Virus isolation (culture) from surface samples (n = 7) was negative.
CONCLUSIONS
The presence of viral RNA on no-touch surfaces is evidence of viral dissemination through air, but the lack of airborne viral particles in air samples suggests that they were not aerosolized in a significant manner during air sampling sessions. The air samples were collected 8 to 30 days after the residents' symptom onset, which could indicate that viruses are aerosolized early in the infection process. Additional research is needed to evaluate viral viability conservation and the potential role of direct contact and aerosols in SARS-CoV-2 transmission in these institutions.

Identifiants

pubmed: 33587983
pii: S0196-6553(21)00059-6
doi: 10.1016/j.ajic.2021.02.004
pmc: PMC7879049
pii:
doi:

Substances chimiques

Aerosols 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

701-706

Informations de copyright

Copyright © 2021 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Références

PLoS One. 2017 Jul 20;12(7):e0181558
pubmed: 28727803
Nat Commun. 2021 Jan 11;12(1):267
pubmed: 33431879
EBioMedicine. 2020 Sep;59:102960
pubmed: 32853988
Sci Rep. 2020 Jul 29;10(1):12732
pubmed: 32728118
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
Am J Respir Crit Care Med. 2020 Sep 1;202(5):651-659
pubmed: 32543913
Nature. 2020 Jun;582(7813):557-560
pubmed: 32340022
JAMA Intern Med. 2020 Dec 1;180(12):1665-1671
pubmed: 32870239
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163
pubmed: 32356867
Emerg Microbes Infect. 2020 Dec;9(1):2597-2605
pubmed: 33206022
Emerg Infect Dis. 2020 Jul;26(7):1628-1631
pubmed: 32240078
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
J Am Geriatr Soc. 2020 Sep;68(9):1899-1906
pubmed: 32557542
J Infect Dis. 2005 May 1;191(9):1472-7
pubmed: 15809906
Emerg Infect Dis. 2020 Jul;26(7):1583-1591
pubmed: 32275497
J Aerosol Sci. 2009 Feb;40(2):122-133
pubmed: 32287373
Lancet Public Health. 2020 Apr;5(4):e188-e189
pubmed: 32197116
Clin Infect Dis. 2021 May 18;72(10):e652-e654
pubmed: 32857833
Age Ageing. 2010 May;39(3):299-305
pubmed: 20332371
Indoor Air. 2005 Apr;15(2):83-95
pubmed: 15737151
Clin Infect Dis. 2020 Dec 3;71(9):2311-2313
pubmed: 32628269
Nat Med. 2020 Jun;26(6):861-868
pubmed: 32327757
Clin Microbiol Rev. 2020 Oct 28;34(1):
pubmed: 33115724
Cell. 2020 Jul 23;182(2):429-446.e14
pubmed: 32526206
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):339-342
pubmed: 32214083
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Proc Natl Acad Sci U S A. 2021 Feb 23;118(8):
pubmed: 33536312
N Engl J Med. 2004 Apr 22;350(17):1731-9
pubmed: 15102999
Gastroenterology. 2020 Jul;159(1):81-95
pubmed: 32251668
Environ Int. 2020 Jun;139:105730
pubmed: 32294574
Nat Med. 2020 May;26(5):676-680
pubmed: 32371934
Clin Infect Dis. 2021 Jul 1;73(1):170-171
pubmed: 32857130
JAMA. 2020 Apr 21;323(15):1488-1494
pubmed: 32125362
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
JAMA. 2020 Apr 28;323(16):1610-1612
pubmed: 32129805
Virol J. 2020 Oct 7;17(1):145
pubmed: 33028356
N Engl J Med. 2003 Dec 18;349(25):2416-22
pubmed: 14681507
Sci Total Environ. 2021 Jan 20;753:141710
pubmed: 32891988
Nat Commun. 2020 May 29;11(1):2800
pubmed: 32472043

Auteurs

Nathan Dumont-Leblond (N)

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC, Canada.

Marc Veillette (M)

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC, Canada.

Luc Bhérer (L)

Centre Intégré Universitaire en Santé et Services Sociaux de la Capitale-Nationale, Quebec City, QC, Canada.

Karine Boissoneault (K)

Centre Intégré Universitaire en Santé et Services Sociaux de la Capitale-Nationale, Quebec City, QC, Canada.

Samira Mubareka (S)

Sunnybrook Research Institute and Department of Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada.

Lily Yip (L)

Sunnybrook Research Institute and Department of Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada.

Marie-Eve Dubuis (ME)

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC, Canada.

Yves Longtin (Y)

Jewish General Hospital, Montreal, QC, Canada; Lady Davis Research Institute, Montreal, QC, Canada.

Philippe Jouvet (P)

Université de Montréal, St. Justine Hospital, Department of Pediatrics, Montreal, QC, Canada.

Alison McGeer (A)

Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

Caroline Duchaine (C)

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC, Canada; Département de Biochimie, de Microbiologie et de Bio-informatique, Faculté des Sciences et de Génie, Université Laval, Quebec City, QC, Canada; Canada Research Chair on Bioaerosols, Quebec city, QC, Canada. Electronic address: Caroline.Duchaine@bcm.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH